Budget 2017 through the eyes of patients

Contributed by Steve Sampson, VP Health and Life Sciences, Global Public Affairs Key points from Budget 2017: Major transfers to Provinces remain as negotiated (3% annual increase, plus targeted funds for home care and mental health); additional funding to NIHB of $305m/five years. Additional funds identified in the coming years for Health Canada, PMPRB and CADTH for pharmaceuticals to support “improved access, lower prices, and

Patient advocacy experts gather to start a conversation on cancer immunotherapy in Canada

Inaugural patient summit brings together experts across oncology to collaborate on patient access to innovative cancer treatments and foster collaboration amongst patient groups and the medical community to improve patient outcomes TORONTO, March 27, 2017 /CNW/ – The Immuno-Oncology Network for Patient Organizations today announced its inaugural Patient Leader Education Summit, scheduled for Friday, March 31 to Saturday, April 1, 2017 at the St. James

Ontario Latest Province to Cover Cost of Immuno-Oncology Treatment OPDIVO® (nivolumab)

Eligible Ontario residents with difficult-to-treat advanced cancers can now access an innovative new treatment option without having to pay out-of-pocket. MONTREAL, QUEBEC – March 22, 2017 – Bristol-Myers Squibb Canada Co. (BMS Canada) today announced that Cancer Care Ontario and the Ontario Ministry of Health and Long-Term Care have agreed to cover the cost of the immuno-oncology treatment OPDIVO® for three different difficultto-treat tumour types,

Asbestos is a dangerous substance much like lead

Written by: The Mesothelioma Cancer Alliance It seems almost everyone today knows asbestos is a dangerous substance much like lead. If pressed however, it can be confusing why that is. In truth, asbestos has been used for thousands of years dating back to the ancient Greeks. It amazed people throughout history with its ability to prevent and halt fires if used in building materials. It

Drug Pricing Policy Summit forms working groups to move themes into action

Drug Pricing Policy Working Group Media Release For immediate release: TORONTO, ON – In November 2016, over 40 patient groups met in Toronto for the first Drug Pricing Policy in Canada Summit. Hosted by the Canadian Cancer Survivor Network (@survivornetca) along with the Save Your Skin Foundation (@saveyourskinfdn) and the Schizophrenia Society of Ontario (@peace_of_minds), the two-day event offered a space for patients, patient advocates,